A Trial of MHB088C in Advanced Extrapulmonary Neuroendocrine Cancer
NCT06951243
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Advanced Extrapulmonary Neuroendocrine Cancer
Interventions
DRUG:
MHB088C for Injection (B7-H3 ADC)
Sponsor
Beijing GoBroad Hospital